- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor: Data from Multi-Institutional Registry.
October 14, 2021
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study.
October 14, 2021
Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy.
October 13, 2021
Does neoadjuvant chemotherapy diminish the sex disparity in bladder cancer survival after radical cystectomy?
October 13, 2021
Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.
October 13, 2021
Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients.
October 12, 2021
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture.
October 12, 2021
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.
October 12, 2021
Recombinant BCGs for tuberculosis and bladder cancer.
October 11, 2021
Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non-muscle-invasive bladder cancer: Pro.
October 11, 2021
Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.
October 11, 2021
Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency.
October 9, 2021
γδ T cells support antigen-specific αβ T cell-mediated antitumor responses during BCG treatment for bladder cancer.
October 7, 2021
M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer.
October 7, 2021
